help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rydziel, S.
Right arrow Articles by Canalis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rydziel, S.
Right arrow Articles by Canalis, E.

Endocrinology, Vol 136, 4254-4260, Copyright © 1995 by Endocrine Society

ARTICLES

Cortisol represses insulin-like growth factor II receptor transcription in skeletal cell cultures

S Rydziel and E Canalis
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA.

Glucocorticoids have a number of effects on bone cell function, some of which might be mediated by changes in the synthesis or activity of insulin-like growth factors (IGFs). Glucocorticoids inhibit IGF-I, but not IGF-II, synthesis in osteoblasts and decrease the expression of selected IGF-binding proteins. The effects of glucocorticoids on IGF-I and -II receptor messenger RNA (mRNA) expression in osteoblasts are not known, and changes in IGF-I or -II receptor levels could result in changes in IGF activity. We examined the effects of glucocorticoids on IGF-I and -II receptor mRNA expression in cultures of osteoblast- enriched cells from 22-day-old fetal rat calvariae (Ob cells). Cortisol at 1 microM for 2-48 h did not alter IGF-I receptor transcripts, as determined by Northern blot analysis and ribonuclease protection assay. In contrast, cortisol caused a time- and dose-dependent inhibition of IGF-II receptor mRNA levels. The effect was maximal at 0.1-1 microM for 24-48 h and was accompanied by a decrease in IGF-II receptor levels, as determined by affinity labeling, cross-linking and polyacrylamide gel electrophoresis, Western immunoblot, and Scatchard analysis. The effect of cortisol on IGF-II receptor transcripts was not dependent on de novo protein synthesis. Cortisol did not modify the IGF-II receptor mRNA half-life in transcriptionally arrested Ob cells and decreased the rate of IGF-II receptor RNA transcription in nuclear run-on assays. In conclusion, cortisol decreases transcription of the IGF-II receptor in Ob cell cultures, an effect that could mediate selected actions of glucocorticoids in bone.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. Reini, C. E. Wood, E. Jensen, and M. Keller-Wood
Increased maternal cortisol in late-gestation ewes decreases fetal cardiac expression of 11beta-HSD2 mRNA and the ratio of AT1 to AT2 receptor mRNA
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1708 - R1716.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M.-F. Iu, H. Kaji, H. Sowa, J. Naito, T. Sugimoto, and K. Chihara
Dexamethasone suppresses Smad3 pathway in osteoblastic cells
J. Endocrinol., April 1, 2005; 185(1): 131 - 138.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Blanquaert, R. C. Pereira, and E. Canalis
Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E509 - E515.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. O. Abu, A. Horner, V. Kusec, J. T. Triffitt, and J. E. Compston
The Localization of the Functional Glucocorticoid Receptor {alpha} in Human Bone
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 883 - 889.
[Abstract] [Full Text]

Home page
 ChestHome page
M. F. Goldstein, J. J. Fallon Jr, and R. Harning
Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease*
Chest, December 1, 1999; 116(6): 1733 - 1749.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Dennison, P. Hindmarsh, C. Fall, S. Kellingray, D. Barker, D. Phillips, and C. Cooper
Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3058 - 3063.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
T. Kawane and N. Horiuchi
Insulin-Like Growth Factor I Suppresses Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Expression via a Mitogen-Activated Protein Kinase Pathway in UMR-106 Osteoblast-Like Cells
Endocrinology, February 1, 1999; 140(2): 871 - 879.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
V. Gangji, S. Rydziel, B. Gabbitas, and E. Canalis
Insulin-Like Growth Factor II Promoter Expression in Cultured Rodent Osteoblasts and Adult Rat Bone
Endocrinology, May 1, 1998; 139(5): 2287 - 2292.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. P.J. King, M.-J. Tseng, C. D. Logsdon, N. Billestrup, and C. Carter-Su
Distinct Cytoplasmic Domains of the Growth Hormone Receptor Are Required for Glucocorticoid- and Phorbol Ester-induced Decreases in Growth Hormone (GH) Binding. THESE DOMAINS ARE DIFFERENT FROM THAT REPORTED FOR GH-INDUCED RECEPTOR INTERNALIZATION
J. Biol. Chem., July 26, 1996; 271(30): 18088 - 18094.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society